LENSAR (NASDAQ:LNSR) Shares Up 1% – Should You Buy?

LENSAR, Inc. (NASDAQ:LNSR) was up 1% on Thursday . The stock traded as high as $11.99 and last traded at $11.99. Approximately 23,354 shares were traded during mid-day trading, a decline of 31% from the average daily volume of 33,894 shares. The stock had previously closed at $11.87.

Analyst Ratings Changes

A number of equities analysts have weighed in on LNSR shares. Wall Street Zen upgraded LENSAR to a “hold” rating in a research note on Friday, November 28th. Weiss Ratings reiterated a “sell (d-)” rating on shares of LENSAR in a research report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, LENSAR has a consensus rating of “Reduce” and a consensus price target of $15.00.

LENSAR Price Performance

The firm’s 50 day moving average price is $11.10 and its 200 day moving average price is $12.02. The stock has a market capitalization of $143.16 million, a P/E ratio of -2.73 and a beta of 0.70.

LENSAR (NASDAQ:LNSR) last posted its earnings results on Thursday, November 6th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.23). The company had revenue of $14.32 million during the quarter, compared to the consensus estimate of $17.75 million.

Institutional Trading of LENSAR

Large investors have recently added to or reduced their stakes in the stock. Brandes Investment Partners LP raised its holdings in LENSAR by 3.5% in the 2nd quarter. Brandes Investment Partners LP now owns 563,581 shares of the company’s stock worth $7,422,000 after purchasing an additional 18,894 shares in the last quarter. Vanguard Group Inc. increased its position in shares of LENSAR by 0.3% during the third quarter. Vanguard Group Inc. now owns 507,603 shares of the company’s stock valued at $6,269,000 after buying an additional 1,446 shares during the period. Groupe la Francaise increased its position in shares of LENSAR by 99.5% during the second quarter. Groupe la Francaise now owns 251,400 shares of the company’s stock valued at $3,311,000 after buying an additional 125,400 shares during the period. Geode Capital Management LLC raised its stake in LENSAR by 103.9% in the second quarter. Geode Capital Management LLC now owns 219,373 shares of the company’s stock worth $2,890,000 after buying an additional 111,802 shares in the last quarter. Finally, Credit Industriel ET Commercial lifted its holdings in LENSAR by 98.4% in the second quarter. Credit Industriel ET Commercial now owns 168,600 shares of the company’s stock worth $2,220,000 after buying an additional 83,600 shares during the period. Institutional investors own 40.15% of the company’s stock.

LENSAR Company Profile

LENSAR, Inc, headquartered in Orlando, Florida, is a medical technology company specializing in advanced laser systems for ophthalmic surgery. Its flagship product, the LENSAR Laser System, combines proprietary three-dimensional imaging with precision-guided femtosecond laser delivery to perform critical steps in cataract procedures, including capsulotomy creation, lens fragmentation and corneal incisions.

Founded in 2005, LENSAR has concentrated its research and development efforts on enhancing surgical accuracy and patient outcomes in cataract treatment.